Miles Houslay

Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom.

Ampika Ltd. discovers and develops drugs. It develops consumer products and prescription drugs from plant-based compounds. Its products includes cardiovascular protection, anti-infectives, diabetes, oncology, dermatological conditions and neurological. The company was founded by Francoise Barbira Freedman, Margaret Adey, Paul Rodgers and Jonathan Mark Treherne in May 2003 and is headquartered in Cambridge, the United Kingdom.

Ithaka Life Sciences Ltd. provides advisory, guidance, and support for the life science industry. The British company was founded by Paul Barton Rodgers, who has been the CEO since incorporation.

ProteinLogic Ltd. has developed a diagnostic technology platform called immiprint®, which detects non-obvious diagnostic patterns in soluble immune proteins in the blood and other body fluids through machine learning. ProteinLogic is based in Cambridge, UK. These patterns form unique signatures of disease presence, stage, and potential response to treatment. The immiprint® technology has been clinically validated with the development of a signature in blood for the ruling out of active tuberculosis (TB), meeting the stringent criteria of the WHO for such a diagnostic test. The British company expects to create considerable additional value through the validation of other immiprint® signatures in its early stage development pipeline, with a focus on infectious, autoimmune, and inflammatory diseases.